Following acute or repetitive ischemic episodes, persistent immune activation-mediated through interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α)-promotes endothelial dysfunction, microvascular instability, and extracellular matrix remodeling. This evidence concerns the gene IL1B and endothelial dysfunction.